BPG is committed to discovery and dissemination of knowledge
Articles in Press
4/1/2026 6:45:10 AM | Browse: 5 | Download: 0
| Category |
Oncology |
| Manuscript Type |
Retrospective Study |
| Article Title |
ST2, PIVKA-II, CEA, CA125 and their combinations in elderly liver metastases cancers: Development of a diagnostic scoring model
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Yun Cheng, Yan-Sha Sun and Yong-Ming He |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Yun Cheng, Associate Chief Physician, Department of Integrated Traditional Chinese Medicine and Western, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, No. 42 Baiziting, Nanjing 210009, Jiangsu Province, China. chengyun_nj@163.com |
| Key Words |
Soluble growth-stimulating gene 2; Protein induced by vitamin K absence or antagonist-II; Carcinoembryonic antigen; Carbohydrate antigen 125; Liver metastasis; Lung cancer; Colorectal cancer; Scoring model |
| Core Tip |
Based on the logistic regression analysis, a risk scoring model incorporating soluble growth-stimulating gene 2, protein induced by vitamin K absence or antagonist-II, carcinoembryonic antigen, carbohydrate antigen 125, and fatty liver history was developed to predict liver metastasis in elderly colorectal and lung cancer patients. The soluble growth-stimulating gene 2 + protein induced by vitamin K absence or antagonist-II + carcinoembryonic antigen + carbohydrate antigen 125 combination achieved the optimal diagnostic balance (area under the curve = 0.896), with specificity reaching 98.42%. Risk stratification significantly correlated with metastasis incidence (93.2% in high-risk vs 10.4% in low-risk). This quantitative model provides a simple, non-invasive tool for early identification of high-risk patients, facilitating personalized surveillance and timely intervention. |
| Citation |
Cheng Y, Sun YS, He YM. ST2, PIVKA-II, CEA, CA125 and their combinations in elderly liver metastases cancers: Development of a diagnostic scoring model. World J Gastrointest Oncol 2026; In press |
 |
Received |
|
2026-01-30 09:48 |
 |
Peer-Review Started |
|
2026-01-30 09:48 |
 |
First Decision by Editorial Office Director |
|
2026-02-10 09:01 |
 |
Return for Revision |
|
2026-02-10 09:01 |
 |
Revised |
|
2026-02-12 12:12 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2026-04-01 02:45 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2026-04-01 06:45 |
 |
Articles in Press |
|
2026-04-01 06:45 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345